Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BTK |
| Variant | V568I |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BTK V568I lies within the protein kinase domain of the Btk protein (UniProt.org). V568I retains binding to Plcg2 and Cdc37, but results in decreased protein stability and expression, loss of Plcg2 phosphorylation and Btk autophosphorylation, and leads to elevated phosphorylation of Akt in anti-immunoglobulin treated cells in culture (PMID: 33419778). |
| Associated Drug Resistance | |
| Category Variants Paths |
BTK mutant BTK inact mut BTK V568I |
| Transcript | NM_000061.3 |
| gDNA | chrX:g.101353918C>T |
| cDNA | c.1702G>A |
| Protein | p.V568I |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000061.2 | chrX:g.101353918C>T | c.1702G>A | p.V568I | RefSeq | GRCh38/hg38 |
| NM_000061.3 | chrX:g.101353918C>T | c.1702G>A | p.V568I | RefSeq | GRCh38/hg38 |
| NM_001287344.1 | chrX:g.101354661C>T | c.1702G>A | p.V568I | RefSeq | GRCh38/hg38 |
| NM_001287344.2 | chrX:g.101354661C>T | c.1702G>A | p.V568I | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|